2024;18(1):e59e69
Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, et al
BoiaFerreira et al
Affordable Care Act Marketplace plans often cover GLP-1 drugs, such as Ozempic, that have been approved for treatment of type 2 diabetes, but seldom cover those approved for obesity, like Wegovy and Zepbound
However, the emerging paradigm recognizes microglia as exquisitely plastic cells capable of adopting diverse functional states, including neuroprotective phenotypes that may actually counteract disease progression under certain conditions [120, 123, 456]
Specifically, phosphorylated RB interacts with the NF-B protein p65, effectively inhibiting the transcriptional activity of NF-B (Narasimha et al., 2014)